Skip Navigation

Akarna Therapeutics

Developing Best-in-Class Therapeutics Targeting Inflammatory Diseases

  • CEO: Raju Mohan
  • Location: Encinitas, CA
  • Milestones: Jul 2015 - Third Point Ventures initial investment, Aug 2016 - Akarna acquired by Allergan (NYSE: AGN)
Go to site

Akarna Therapeutics is a privately held biopharmaceutical company developing novel small molecule therapeutics that target inflammatory and fibrotic diseases for which there is no approved treatment.